No results found for “”
No results found for filter “”
-
Blog articles 16.07.21
Beyond the Basics: Tackling post-Covid healthcare challenges in Central and Eastern Europe (Guest blog)...
We need to start to reimagine our healthcare systems. We cannot afford to go back to where we were before. Now is the time for under-resourced and often,...
Read Article -
Statements & press releases 14.07.21
Health Systems after COVID-19 – charting a course for a healthier Europe
EFPIA believes that once we emerge from this crisis, we should not only rebuild our economies and get our societies back on their feet, but also take the...
Read Article -
Blog articles 14.07.21
Nobody Left Outside (Guest blog)
Through advocacy and policy briefs, the NLO coalition has been instrumental in raising awareness of the challenges faced by underserved and stigmatized...
Read Article -
Blog articles 13.07.21
Patient Engagement. A personal, organisational and cross-industry priority that needs to drive what we...
A blog by Nathalie Moll
Read Article -
Statements & press releases 06.07.21
Global regulators and coalition of pharma and vaccine manufacturing associations come together to discuss...
An opportunity to discuss and harmonize the regulatory strategies, approaches and tools that can enable pharmaceutical product manufacturers to increase...
Read Article -
Statements & press releases 23.06.21
EU HTA; compromise but at what cost?
Now, more than ever, Europe needs to speak with a coherent voice on clinical evidence in the best interests of patients and our healthcare systems.
Read Article -
Blog articles 23.06.21
What do Formula 1 and EU access to medicines have in common? Turns out 4 key “drivers” (Guest blog)
Healthcare stakeholders need to work together, in the same way F1 teams work: as one entity pursuing the same goal.
Read Article -
Statements & press releases 22.06.21
Biopharmaceutical CEO Brussels meeting with EU leaders focuses on equitable access to tackle COVID-19,...
Working together to be better prepared for future pandemics, to bring the best practices from the last 18 months into business as usual and to be ready...
Read Article -
Statements & press releases 21.06.21
A strategic research & innovation agenda for a healthier Europe
A joint statement from COCIR, EFPIA, MedTech Europe, EuropaBio and Vaccines Europe
Read Article -
Blog articles 17.06.21
Unlocking the potential of the European Health Data Space to improve diabetes management in crises and...
The COVID-19 pandemic in particular has revealed the extent with which diabetes is intertwined with other social determinants, creating a multidimensional,...
Read Article -
Blog articles 17.06.21
Regulatory Pathways for an Integral Drug-Device Combination Product Platform based on Quality by Design...
Using a platform approach in the development of an integral drug-device combination product provides an opportunity to streamline the regulatory review...
Read Article -
Statements & press releases 16.06.21
New Presidency team at EFPIA committed to working with EU and Member States to build back better from...
We look forward to working across all stakeholders to build a healthier future for Europe
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 03.12.20
Working together towards better patient outcomes
A new series of short films to showcase innovative partnerships that will change patient outcomes
Read Article -
EFPIA News 14.10.20
Biopharmaceutical industry support EU regulators exceptional transparency measures
And call other regulatory authorities to follow suit to help ensure confidence in the science and the decision-making
Read Article -
EFPIA News 17.09.20
Vaccines Europe Statement on the safety of COVID-19 vaccines
The health and safety of people receiving any vaccine is our first priority, and that applies equally to recipients of a COVID-19 vaccine
Read Article -
EFPIA News 10.06.20
Connecting Healthcare Awards - Submission period extended
The new deadline is 30 September 2020
Read Article -
EFPIA News 23.04.20
Europe’s COVID-19 battle: Getting the data we need to ensure the supply of medicines
A major part of the solution is the provision of detailed, accurate forecasting data from the European Centre for Disease Control (ECDC) on the patient-level...
Read Article -
EFPIA News 22.04.20
Coronavirus – your questions answered
What is the industry in Europe doing to help in the fight against the coronavirus? What are the risks of drug shortage caused by the coronavirus?
Read Article -
EFPIA News 20.04.20
Exscalate4Cov project: Call for Collaboration by DG Connect
The European Commission (DG Connect) is looking for industry partners to join the Exscalate4Cov project, seeking to accelerate identification of medicines...
Read Article -
EFPIA News 08.04.20
Official Update on the Connecting Healthcare Awards
A special COVID-19 category now available
Read Article -
EFPIA News 05.03.20
Connecting Healthcare Awards 2020 – Apply Now
Turn the spotlight on collaborative projects that make a difference to patients across Europe
Read Article -
EFPIA News 05.03.20
EFPIA's input to the EU's Beating Cancer Plan Roadmap consultation
The research-based pharmaceutical industry remains committed to improving cancer prevention, diagnosis, treatment and quality of life of patients.
Read Article -
EFPIA News 20.02.20
IMI opens registrations for a webinar on the Coronavirus Call
The Innovative Medicines Initiative to launch EUR 45 million Call for proposals on COVID-19 early March
Read Article -
EFPIA News 10.02.20
EFPIA, Medicines for Europe and AESGP call for a Mutual Recognition Agreement on Good Manufacturing Practice...
The pharmaceutical industry in Europe has worked to support the EU27 and UK to reach an agreement that will allow patients to receive medicines and medical...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 14.07.21
Health Systems after COVID-19 – charting a course for a healthier Europe
EFPIA believes that once we emerge from this crisis, we should not only rebuild our economies and get our societies back on their feet, but also take the...
Read Article -
Statements & press releases 06.07.21
Global regulators and coalition of pharma and vaccine manufacturing associations come together to discuss...
An opportunity to discuss and harmonize the regulatory strategies, approaches and tools that can enable pharmaceutical product manufacturers to increase...
Read Article -
Statements & press releases 23.06.21
EU HTA; compromise but at what cost?
Now, more than ever, Europe needs to speak with a coherent voice on clinical evidence in the best interests of patients and our healthcare systems.
Read Article -
Statements & press releases 22.06.21
Biopharmaceutical CEO Brussels meeting with EU leaders focuses on equitable access to tackle COVID-19,...
Working together to be better prepared for future pandemics, to bring the best practices from the last 18 months into business as usual and to be ready...
Read Article -
Statements & press releases 21.06.21
A strategic research & innovation agenda for a healthier Europe
A joint statement from COCIR, EFPIA, MedTech Europe, EuropaBio and Vaccines Europe
Read Article -
Statements & press releases 16.06.21
New Presidency team at EFPIA committed to working with EU and Member States to build back better from...
We look forward to working across all stakeholders to build a healthier future for Europe
Read Article -
Statements & press releases 15.06.21
The pharmaceutical industry: a key asset to medical progress and the European economy
The Pharmaceutical Industry in Figures 2021
Read Article -
Statements & press releases 15.06.21
EFPIA response to EPSCO discussion on access to medicines and medical devices for a stronger and resilient...
Three steps to faster more equitable access to therapies in Europe
Read Article -
Statements & press releases 08.06.21
New ECIPE study on “International EU27 pharmaceutical production, trade, dependencies and vulnerabilities”...
Faced with the COVID-19 pandemic, global supply chains have shown remarkable resilience, and open markets and open trade have been one of the key reasons...
Read Article -
Statements & press releases 04.06.21
EFPIA response to the EU Communication on “Urgent Trade Policy Responses to the COVID-19 crisis"
Compulsory licensing will not facilitate greater vaccine equity but could put the hard-won progress in fighting this terrible disease in jeopardy.
Read Article -
Statements & press releases 26.05.21
EFPIA ECPC and Diaceutics call for postponed application and phased implementation of the in vitro diagnostic...
After careful assessment, and should the IVDR be applicable as of 26 May 2022, we believe that European healthcare systems will not be able to assess diagnostics...
Read Article -
Statements & press releases 25.05.21
Alliance for Regenerative Medicine, EFPIA, and European Association for Bioindustries Call for Advanced...
COVID-19 highlights how the EU can adapt legislation to meet urgent health needs. A permanent exemption would help to accelerate access to life-changing...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 16.07.21
Beyond the Basics: Tackling post-Covid healthcare challenges in Central and Eastern Europe (Guest blog)...
We need to start to reimagine our healthcare systems. We cannot afford to go back to where we were before. Now is the time for under-resourced and often,...
Read Article -
Blog articles 14.07.21
Nobody Left Outside (Guest blog)
Through advocacy and policy briefs, the NLO coalition has been instrumental in raising awareness of the challenges faced by underserved and stigmatized...
Read Article -
Blog articles 13.07.21
Patient Engagement. A personal, organisational and cross-industry priority that needs to drive what we...
A blog by Nathalie Moll
Read Article -
Blog articles 23.06.21
What do Formula 1 and EU access to medicines have in common? Turns out 4 key “drivers” (Guest blog)
Healthcare stakeholders need to work together, in the same way F1 teams work: as one entity pursuing the same goal.
Read Article -
Blog articles 17.06.21
Unlocking the potential of the European Health Data Space to improve diabetes management in crises and...
The COVID-19 pandemic in particular has revealed the extent with which diabetes is intertwined with other social determinants, creating a multidimensional,...
Read Article -
Blog articles 17.06.21
Regulatory Pathways for an Integral Drug-Device Combination Product Platform based on Quality by Design...
Using a platform approach in the development of an integral drug-device combination product provides an opportunity to streamline the regulatory review...
Read Article -
Blog articles 14.06.21
Can partnerships help boost vaccine supply? (Guest blog)
An interview with Dr Steffen Lang, Global Head of Novartis Technical Operations and member of the Executive Committee of Novartis
Read Article -
Blog articles 11.06.21
EFPIA Connecting Healthcare Awards – it’s all about how collaboration brings people together to help...
Every project for patients would deserve an award for the effort, for coming together to realize an idea to help patients.
Read Article -
Blog articles 10.06.21
Podcast: From raw materials to patients’ arms – how are COVID-19 vaccines made?
Welcome to 19 Conversations
Read Article -
Blog articles 31.05.21
Podcast: How is the pharmaceutical industry contributing to a healthy environment?
Welcome to 19 Conversations
Read Article -
Blog articles 27.05.21
Industry as a partner to strengthen healthcare systems after COVID-19 (Guest blog)
Catherine Owen, Head of Major Markets at Bristol Myers Squibb, discusses how the pharmaceutical industry has supported healthcare systems to overcome the...
Read Article -
Blog articles 27.05.21
Bladder Cancer Awareness Month: Rising to the Challenge of Bladder Cancer Care (Guest blog)
Although often out of the spotlight, bladder cancer ranks fifth among the most frequently diagnosed cancers
Read Article